We are live on ! Find out more
AC

Apogem Capital Portfolio holdings

AUM $303K
1-Year Est. Return 46.01%
This Fund
S&P 500
This Quarter Est. Return
-3.82%
1 Year Est. Return
-46.01%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$146M
AUM Growth
-$6.11M
Cap. Flow
+$6.8M
Cap. Flow %
4.64%
Top 10 Hldgs %
28.72%
Holding
210
New
36
Increased
52
Reduced
44
Closed
36

Top Buys

Rank Stock Value
1
OEC icon
Orion
OEC
+$3.8M
2
AKTS
Akoustis Technologies Inc
AKTS
+$1.87M
3
VOD icon
Vodafone
VOD
+$1.7M
4
NWG icon
NatWest
NWG
+$1.43M
5
GT icon
Goodyear
GT
+$1.25M

Top Sells

Rank Stock Value
1
FISV
Fiserv Inc
FISV
+$2.19M
2
EZPW icon
Ezcorp Inc
EZPW
+$1.95M
3
ZUO
Zuora, Inc.
ZUO
+$1.48M
4
AON icon
Aon
AON
+$1.18M
5
UPBD icon
Upbound Group
UPBD
+$893K

Sector Composition

Rank Sector Weight
1 Technology 25.53%
2 Industrials 16.72%
3 Consumer Discretionary 15.88%
4 Materials 9.92%
5 Healthcare 8.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MATV icon
101
Mativ Holdings
MATV
$472M
$480K 0.33%
+17,461
New +$526K
PYPL icon
102
PayPal
PYPL
$49.3B
$479K 0.33%
+4,138
New +$551K
SE icon
103
Sea Limited
SE
$65.1B
$479K 0.33%
+4,000
New +$564K
DXPE icon
104
DXP Enterprises
DXPE
$2.4B
$473K 0.32%
+17,450
New +$495K
ALDX icon
105
Aldeyra Therapeutics
ALDX
$96.5M
$462K 0.32%
104,042
+17,312
+20% +$69K
HVT icon
106
Haverty Furniture Companies
HVT
$403M
$442K 0.3%
16,116
NEX
107
DELISTED
NexTier Oilfield Solutions Inc.
NEX
$411K 0.28%
+44,444
New +$318K
GTLB icon
108
GitLab
GTLB
$5.7B
$403K 0.28%
+7,407
New +$442K
SKIN icon
109
SkinHealth Systems
SKIN
$87.6M
$392K 0.27%
23,243
+5,435
+31% +$89.7K
MGTX icon
110
MeiraGTx Holdings
MGTX
$1.11B
$388K 0.27%
+28,045
New +$432K
NWPX icon
111
NWPX Infrastructure Inc
NWPX
$1.22B
$388K 0.27%
15,240
FLR icon
112
Fluor
FLR
$6.99B
$384K 0.26%
+13,400
New +$323K
PARA
113
DELISTED
Paramount Global Class B
PARA
$378K 0.26%
10,000
NVDA icon
114
NVIDIA
NVDA
$4.72T
$372K 0.25%
13,640
-300
-2% -$7.52K
CNVY
115
DELISTED
Convey Health Solutions Holdings, Inc.
CNVY
$367K 0.25%
56,125
-2,381
-4% -$15.7K
KZR
116
DELISTED
Kezar Life Sciences
KZR
$366K 0.25%
2,202
-501
-19% -$71.9K
OSPN icon
117
OneSpan
OSPN
$571M
$365K 0.25%
25,246
+5,000
+25% +$75.5K
BLZE icon
118
Backblaze
BLZE
$758M
$363K 0.25%
33,990
-462
-1% -$5.77K
ARCO icon
119
Arcos Dorados Holdings
ARCO
$1.73B
$352K 0.24%
43,245
-27,706
-39% -$191K
OKTA icon
120
Okta
OKTA
$24.4B
$347K 0.24%
+2,298
New +$412K
TLS icon
121
Telos
TLS
$324M
$341K 0.23%
34,222
-1,444
-4% -$16.2K
MGNI icon
122
Magnite
MGNI
$2.78B
$340K 0.23%
25,750
HCP
123
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
$332K 0.23%
+6,145
New +$357K
BSX icon
124
Boston Scientific
BSX
$68.4B
$331K 0.23%
+7,469
New +$324K
BWMX icon
125
Betterware México
BWMX
$655M
$331K 0.23%
19,461
+8,126
+72% +$158K

Similar funds

Apogem Capital's Q1 2022 Portfolio in Review

As of Q1 2022, Apogem Capital held 210 positions worth $146M, down 4% from $152M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Apogem Capital deployed $6.8M of net new capital in Q1 2022, opening 36 new positions and adding to 52 existing holdings. Its largest new stake was Akoustis Technologies Inc: 314,198 shares worth $2.04M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Fiserv Inc, an estimated $2.19M trimmed.

  • Apogem Capital's largest Q1 2022 buy was Akoustis Technologies Inc: 314,198 shares worth $2.04M.
  • Apogem Capital added most to Orion in Q1 2022, an estimated $3.8M increase.
  • Apogem Capital's biggest Q1 2022 reduction was Fiserv Inc, cutting an estimated $2.19M.
  • Apogem Capital fully exited Ezcorp Inc in Q1 2022, selling an estimated $1.95M.
  • Apogem Capital's ten largest holdings make up 29% of its $146M portfolio in Q1 2022.
  • Apogem Capital opened 36 new positions and closed 36 in Q1 2022.
  • Apogem Capital's portfolio value fell 4% quarter-over-quarter to $146M.

Based on Apogem Capital's 13F filing for Q1 2022, filed 16 May 2022.